Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Katan Mira

Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation.

Polymeris AA; Meinel TR; Oehler H; Hölscher K; Zietz A; Scheitz JF; Nolte CH; Stretz C; Yaghi S; Stoll S; Wang R; Häusler KG; Hellwig S; Klammer MG; Litmeier S; Leon Guerrero CR; Moeini-Naghani I; Michel P; Strambo D; Salerno A; Bianco G; Cereda C; Uphaus T; Gröschel K; Katan M; Wegener S; Peters N; Engelter ST; Lyrer PA; Bonati LH; Grunder L; Ringleb PA; Fischer U; Kallmünzer B; Purrucker JC; Seiffge DJ. Journal of neurology, neurosurgery, and psychiatry. 2022.

A novel biomarker panel index improves risk stratification after ischemic stroke

Bicvic A.; Scherrer N.; Schweizer J.; Fluri F.; Christ-Crain M.; De Marchis G.M.; Luft A.R.; Katan M.. European stroke journal. 2022.

Blood Pressure Variability Indices for Outcome Prediction After Thrombectomy in Stroke by Using High-Resolution Data

Inauen C.; Boss J.M.; Katan M.; Luft A.R.; Kulcsar Z.; Willms J.F.; Bogli S.Y.; Keller E.. Neurocritical Care. 2022.

Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.

Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M. Journal of the American College of Cardiology. 2022.

Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion

Bicciato G.; Arnold M.; Gebhardt A.; Katan M.. Current Opinion in Neurology. 2022.

Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.

du Fay de Lavallaz J; Prepoudis A; Wendebourg MJ; Kesenheimer E; Kyburz D; Daikeler T; Haaf P; Wanschitz J; Löscher WN; Schreiner B; Katan M; Jung HH; Maurer B; Hammerer-Lercher A; Mayr A; Gualandro DM; Acket A; Puelacher C; Boeddinghaus J; Nestelberger T; Lopez-Ayala P; Glarner N; Shrestha S; Manka R; Gawinecka J; Piscuoglio S; Gallon J; Wiedemann S; Sinnreich M; Mueller C; BASEL XII Investigators.. Circulation. 2022.

A Good Start to Shed More Light on the Relationship Between Glycemic Traits, Diabetes Mellitus, and Cerebrovascular Disease

Arnold M.; Gill D.; Katan M.. Neurology. 2021.

A panel comprising serum amyloid a, white blood cells and nihss for the triage of patients at low risk of post-stroke infection

Gil L.A.; Krattinger-Turbatu L.; Schweizer J.; Katan M.; Sanchez J.-C.. Diagnostics. 2021.

Cancer is associated with inferior outcome in patients with ischemic stroke

Seystahl K.; Hug A.; Weber S.J.; Kapitza S.; Gramatzki D.; Wanner M.; Katan M.; Luft A.R.; Rohrmann S.; Wegener S.; Weller M.. Journal of neurology. 2021.

C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke

Westphal L.P.; Schweizer J.; Fluri F.; De Marchis G.M.; Christ-Crain M.; Luft A.R.; Katan M.. Frontiers in neurology. 2021.

Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.

Arnold M; Schweizer J; Nakas CT; Schütz V; Westphal LP; Inauen C; Pokorny T; Luft A; Leichtle A; Arnold M; Bicvic A; Fischer U; De Marchis GM; Bonati LH; Müller MD; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Foerch C; Spanaus K; von Eckardstein A; Katan M. European heart journal. 2021.

Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation

Meinel T.R.; Branca M.; De Marchis G.M.; Nedeltchev K.; Kahles T.; Bonati L.; Arnold M.; Heldner M.R.; Jung S.; Carrera E.; Dirren E.; Michel P.; Strambo D.; Cereda C.W.; Bianco G.; Kagi G.; Vehoff J.; Katan M.; Bolognese M.; Backhaus R.; Salmen S.; Albert S.; Medlin F.; Berger C.; Schelosky L.; Renaud S.; Niederhauser J.; Bonvin C.; Schaerer M.; Mono M.-L.; Rodic B.; Tarnutzer A.A.; Mordasini P.; Gralla J.; Kaesmacher J.; Engelter S.; Fischer U.; Seiffge D.J.. Annals of neurology. 2021.

Secondary prevention of ischemic stroke: Laboratory and imaging biomarkers

Katan M.; Wegener S.. Therapeutische Umschau. Revue therapeutique. 2021.

Seizures after Ischemic Stroke: A Matched Multicenter Study

Ferreira-Atuesta C.; Dohler N.; Erdelyi-Canavese B.; Felbecker A.; Siebel P.; Scherrer N.; Bicciato G.; Schweizer J.; Sinka L.; Imbach L.L.; Katan M.; Abraira L.; Santamarina E.; Alvarez-Sabin J.; Winklehner M.; von Oertzen T.J.; Wagner J.N.; Gigli G.L.; Serafini A.; Janes F.; Merlino G.; Valente M.; Gregoraci G.; Conrad J.; Evers S.; Lochner P.; Roell F.; Brigo F.; Bentes C.; Peralta A.R.; Melo T.P.E.; Keezer M.R.; Duncan J.S.; Sander J.W.; Tettenborn B.; Koepp M.J.; Galovic M.. Annals of neurology. 2021.

External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers

Hotter B.; Hoffmann S.; Ulm L.; Meisel C.; Bustamante A.; Montaner J.; Katan M.; Smith C.J.; Meisel A.. Stroke. 2020.

Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients with Stroke Is Unaltered over Time

Arnold M.; Nakas C.; Luft A.; Christ-Crain M.; Leichtle A.; Katan M.. Stroke. 2020.

Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke

Gruber P.; Fluri F.; Schweizer J.; Luft A.; Muller B.; Christ-Crain M.; Katan M.. Clinical and Applied Thrombosis/Hemostasis. 2020.

Promising Use of Automated Electronic Phenotyping: Turning Big Data into Big Value in Stroke Research

Aguiar De Sousa D.; Katan M.. Stroke. 2020.

SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections

Schweizer J.; Bustamante A.; Lapierre-Fetaud V.; Faura J.; Scherrer N.; Azurmendi Gil L.; Fluri F.; Schutz V.; Luft A.; Boned S.; Sanchez J.-C.; Montaner J.; Katan M.. Stroke. 2020.

A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score

De Marchis G.M.; Dankowski T.; Konig I.R.; Fladt J.; Fluri F.; Gensicke H.; Foerch C.; Findling O.; Kurmann R.; Fischer U.; Luft A.; Buhl D.; Engelter S.T.; Lyrer P.A.; Christ-Crain M.; Arnold M.; Katan M.. Neurology. 2019.

Antibiotic treatment for pneumonia complicating stroke: Recommendations from the pneumonia in stroke consensus (PISCES) group

Kishore A.K.; Jeans A.R.; Garau J.; Bustamante A.; Kalra L.; Langhorne P.; Chamorro A.; Urra X.; Katan M.; Napoli M.D.; Westendorp W.; Nederkoorn P.J.; van de Beek D.; Roffe C.; Woodhead M.; Montaner J.; Meisel A.; Smith C.J.. European stroke journal. 2019.

ECG monitoring after acute ischemic stroke: Does patient selection matter?

Katan M.; Lubitz S.A.. Neurology. 2019.

Haptoglobin and hemoglobin in subarachnoid hemorrhage A tale of 2 globins

Loch Macdonald R.; Katan M.. Neurology. 2019.

Women in the European Stroke Organisation: One, two, many… – A Top Down and Bottom Up approach

Sandset E.C.; de Sousa D.A.; Christensen H.; Cordonnier C.; Fischer U.; Katan M.; Kremer C.; Pavlovic A.; Sprigg N.; Bart van der Worp H.; Zedde M.; Caso V.. European stroke journal. 2019.

Getting the First Grant

Wegener S.; Katan M.. Stroke. 2018.

Global Burden of Stroke

Katan M.; Luft A.. Seminars in Neurology. 2018.

Incorporating Biomarkers Into a Stroke Research Career

De Marchis G.M.; Garcia-Berrocoso T.; Elkind M.S.V.; Katan M.. Stroke. 2018.

Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke

De Marchis G.M.; Schneider J.; Weck A.; Fluri F.; Fladt J.; Foerch C.; Mueller B.; Luft A.; Christ-Crain M.; Arnold M.; Katan M.. Neurology. 2018.

Serum neurofilament light chain in patients with acute cerebrovascular events

De Marchis G.M.; Katan M.; Barro C.; Fladt J.; Traenka C.; Seiffge D.J.; Hert L.; Gensicke H.; Disanto G.; Sutter R.; Peters N.; Sarikaya H.; Goeggel-Simonetti B.; El-Koussy M.; Engelter S.; Lyrer P.A.; Christ-Crain M.; Arnold M.; Kuhle J.; Bonati L.H.. European journal of neurology. 2018.

Coming to the United States for a Stroke Research Fellowship

Li Z.; Katan M.. Stroke. 2017.

Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study

Blum C.A.; Winzeler B.; Nigro N.; Schuetz P.; Biethahn S.; Kahles T.; Mueller C.; Timper K.; Haaf K.; Tepperberg J.; Amort M.; Huber A.; Bingisser R.; Sandor P.S.; Nedeltchev K.; Muller B.; Katan M.; Christ-Crain M.. Journal of Headache and Pain. 2017.

C-reactive protein in the detection of post-stroke infections: systematic review and individual participant data analysis

Bustamante A.; Vilar-Bergua A.; Guettier S.; Sanchez-Poblet J.; Garcia-Berrocoso T.; Giralt D.; Fluri F.; Topakian R.; Worthmann H.; Hug A.; Molnar T.; Waje-Andreassen U.; Katan M.; Smith C.J.; Montaner J.. Journal of Neurochemistry. 2017.

Microrna 150-5p improves risk classification for mortality within 90 days after acute ischemic stroke

Scherrer N.; Fays F.; Mueller B.; Luft A.; Fluri F.; Christ-Crain M.; Devaux Y.; Katan M.. Journal of stroke. 2017.

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study

Katan M.; Moon Y.; Von Eckardstein A.; Spanaus K.; Derosa J.; Gutierrez J.; Decarli C.; Wright C.; Sacco R.; Elkind M.. Stroke. 2017.

Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: A pilot study

Azurmendi L.; Lapierre-Fetaud V.; Schneider J.; Montaner J.; Katan M.; Sanchez J.-C.. Clinical Proteomics. 2017.

Selection bias in clinical stroke trials depending on ability to consent

Hotter B.; Ulm L.; Hoffmann S.; Katan M.; Montaner J.; Bustamante A.; Meisel A.. BMC Neurology. 2017.

The randomized controlled STRAWINSKI trial: Procalcitonin-guided antibiotic therapy after stroke

Ulm L.; Hoffmann S.; Nabavi D.; Hermans M.; Mackert B.-M.; Hamilton F.; Schmehl I.; Jungehuelsing G.-J.; Montaner J.; Bustamante A.; Katan M.; Hartmann A.; Ebmeyer S.; Dinter C.; Wiemer J.C.; Hertel S.; Meisel C.; Anker S.D.; Meisel A.. Frontiers in neurology. 2017.

Why Is It Worthwhile to Get Involved in Stroke Organizations?

Schmidt A.; Katan M.; Sandset E.C.. Stroke. 2017.

Plasma apelin concentrations in patients with polyuria-polydipsia syndrome

Urwyler S.A.; Timper K.; Fenske W.; De Mota N.; Blanchard A.; Kuhn F.; Frech N.; Arici B.; Rutishauser J.; Kopp P.; Stettler C.; Muller B.; Katan M.; Llorens-Cortes C.; Christ-Crain M.. Journal of Clinical Endocrinology and Metabolism. 2016.

Procalcitonin and midregional proatrial natriuretic peptide as markers of ischemic stroke: The Northern Manhattan study

Katan M.; Moon Y.P.; Paik M.C.; Mueller B.; Huber A.; Sacco R.L.; Elkind M.S.V.. Stroke. 2016.

Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies

Kelly P.J.; Albers G.W.; Chatzikonstantinou A.; De Marchis G.M.; Ferrari J.; George P.; Katan M.; Knoflach M.; Kim J.S.; Li L.; Lee E.-J.; Olivot J.-M.; Purroy F.; Raposo N.; Rothwell P.M.; Sharma V.K.; Song B.; Tsivgoulis G.; Walsh C.; Xu Y.; Merwick A.. The Lancet. Neurology. 2016.

Collagen Vascular and Infectious Diseases

Gutierrez J.; Katan M.; Elkind M.S.V.. . 2015.

Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: A prospective multicenter study

Timper K.; Fenske W.; Kuhn F.; Frech N.; Arici B.; Rutishauser J.; Kopp P.; Allolio B.; Stettler C.; Muller B.; Katan M.; Christ-Crain M.. Journal of Clinical Endocrinology and Metabolism. 2015.

BNP but not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events

Nigro N.; Wildi K.; Mueller C.; Schuetz P.; Mueller B.; Fluri F.; Christ-Crain M.; Katan M.. PLoS One. 2014.

Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: Results from the CoRisk study

De Marchis G.M.; Weck A.; Audebert H.; Benik S.; Foerch C.; Buhl D.; Schuetz P.; Jung S.; Seiler M.; Morgenthaler N.G.; Mattle H.P.; Mueller B.; Christ-Crain M.; Arnold M.; Katan M.. Stroke. 2014.

Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: A pilot study

Frontzek K.; Fluri F.; Siemerkus J.; Muller B.; Gass A.; Christ-Crain M.; Katan M.. PLoS One. 2014.

Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: The Northern Manhattan Study

Katan M.; Moon Y.P.; Paik M.C.; Wolfert R.L.; Sacco R.L.; Elkind M.S.V.. PLoS One. 2014.

Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage

Senn R.; Elkind M.S.V.; Montaner J.; Christ-Crain M.; Katan M.. Cerebrovascular Diseases. 2014.

The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke

Fischer M.; Katan M.; Morgenthaler N.G.; Seiler M.; Muller B.; Lackner P.; Errath M.; Helbok R.; Pfausler B.; Beer R.; Schmutzhard E.; Broessner G.. Cerebrovascular Diseases. 2014.

Copeptin adds prognostic information after ischemic stroke: Results from the CoRisk study

De Marchis G.M.; Katan M.; Weck A.; Fluri F.; Foerch C.; Findling O.; Schuetz P.; Buhl D.; El-Koussy M.; Gensicke H.; Seiler M.; Morgenthaler N.; Mattle H.P.; Mueller B.; Christ-Crain M.; Arnold M.. Neurology. 2013.

Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study

De Marchis G.M.; Katan M.; Weck A.; Brekenfeld C.; Mattle H.P.; Buhl D.; Muller B.; Christ-Crain M.; Arnold M.. International journal of stroke : official journal of the International Stroke Society. 2013.

Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage

Fung C.; de Marchis G.M.; Katan M.; Seiler M.; Arnold M.; Gralla J.; Raabe A.; Beck J.. PLoS One. 2013.

Infectious burden and cognitive function: The Northern Manhattan Study

Katan M.; Moon Y.P.; Paik M.C.; Sacco R.L.; Wright C.B.; Elkind M.S.V.. Neurology. 2013.

Infectious burden and its role in cerebrovascular disease and cognitive impairment

Katan M.; Elkind M.S.V.. Future Virology. 2013.

Prognostic Value of Dehydroepiandrosterone-Sulfate and Other Parameters of Adrenal Function in Acute Ischemic Stroke

Blum C.A.; Mueller C.; Schuetz P.; Fluri F.; Trummler M.; Mueller B.; Katan M.; Christ-Crain M.. PLoS One. 2013.

Copeptin, Procalcitonin and Routine Inflammatory Markers-Predictors of Infection after Stroke

Fluri F.; Morgenthaler N.G.; Mueller B.; Christ-Crain M.; Katan M.. PLoS One. 2012.

Optimizing the risk estimation after a transient ischaemic attack - The ABCDE⊕ score

Engelter S.T.; Amort M.; Jax F.; Weisskopf F.; Katan M.; Burow A.; Bonati L.H.; Hatz F.; Wetzel S.G.; Fluri F.; Lyrer P.A.. European journal of neurology. 2012.

Significance of microbleeds in patients with transient ischaemic attack

Fluri F.; Jax F.; Amort M.; Wetzel S.G.; Lyrer P.A.; Katan M.; Hatz F.; Engelter S.T.. European journal of neurology. 2012.

Anterior pituitary axis hormones and outcome in acute ischaemic stroke

Neidert S.; Katan M.; Schuetz P.; Fluri F.; Ernst A.; Bingisser R.; Kappos L.; Engelter S.T.; Steck A.; Muller B.; Christ-Crain M.. Journal of internal medicine. 2011.

Growth hormone and outcome in patients with intracerebral hemorrhage: A pilot study

Zweifel C.; Katan M.; Schuetz P.; Ernst A.; Mariani L.; Mller B.; Christ-Crain M.. Biomarkers. 2011.

Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke

Katan M.; Elkind M.S.. Expert Review of Neurotherapeutics. 2011.

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

Osthoff M.; Katan M.; Fluri F.; Schuetz P.; Bingisser R.; Kappos L.; Steck A.J.; Engelter S.T.; Mueller B.; Christ-Crain M.; Trendelenburg M.. PLoS One. 2011.

Stress hormones predict cerebrovascular re-events after transient ischemic attacks

Katan M.; Nigro N.; Fluri F.; Schuetz P.; Morgenthaler N.G.; Jax F.; Meckel S.; Gass A.; Bingisser R.; Steck A.; Kappos L.; Engelter S.; Muller B.; Christ-Crain M.. Neurology. 2011.

The role of routine echocardiography in unselected patients with cerebrovascular ischaemic events

Wachter M.; Katan M.; Muzzarelli S.; Rohner A.; Christ-Crain M.; Fluri F.; Bernheim A.M.. European journal of neurology. 2011.

Transient ischemic attack versus transient ischemic attack mimics: Frequency, clinical characteristics and outcome

Amort M.; Fluri F.; Schafer J.; Weisskopf F.; Katan M.; Burow A.; Bucher H.C.; Bonati L.H.; Lyrer P.A.; Engelter S.T.. Cerebrovascular Diseases. 2011.

A confusing patient's history: Small or large vessel vasculitis?

Cantoni N.; Meyer P.; Katan M.; Kappos L.; Hess C.; Daikeler T.. Rheumatology international. 2010.

Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage

Zweifel C.; Katan M.; Schuetz P.; Siegemund M.; Morgenthaler N.G.; Merlo A.; Mueller B.; Christ-Crain M.. BMC Neurology. 2010.

Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke

Katan M.; Fluri F.; Schuetz P.; Morgenthaler N.G.; Zweifel C.; Bingisser R.; Kappos L.; Steck A.; Engelter S.T.; Mller B.; Christ-Crain M.. Journal of the American College of Cardiology. 2010.

Process analysis of explanation and treatment concept for patients with transient ischemic attacks in the university hospital in Basel

Weisskopf F.; Fluri F.; Amort M.; Katan M.; Bingisser R.; Engelter S.T.; Lyrer P.. Schweizer Archiv fur Neurologie und Psychiatrie. 2010.

Prognostic value of copeptin: One-year outcome in patients with acute stroke

Urwyler S.A.; Schuetz P.; Fluri F.; Morgenthaler N.G.; Zweifel C.; Bergmann A.; Bingisser R.; Kappos L.; Steck A.; Engelter S.; Muller B.; Christ-Crain M.; Katan M.. Stroke. 2010.

The stress hormone copeptin: A new prognostic biomarker in acute illness

Katan M.; Christ-Crain M.. Swiss Medical Weekly. 2010.

The stress hormone copeptin: A new prognostic biomarker in acute illness

Katan M.; Christ-Crain M.. Swiss Medical Weekly. 2010.

Copeptin: A novel, independent prognostic marker in patients with ischemic stroke

Katan M.; Fluri F.; Morgenthaler N.G.; Schuetz P.; Zweifel C.; Bingisser R.; Muller K.; Meckel S.; Gass A.; Kappos L.; Steck A.J.; Engelter S.T.; Muller B.; Christ-Crain M.. Annals of neurology. 2009.

Neurological problems during menopause. Estrogen effects on central nervous system disorders: Migraine, stroke and dementia

Katan M.; Kappos L.. Gynakologie. 2009.

Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level

Katan M.; Morgenthaler N.; Widmer I.; Puder J.J.; Konig C.; Muller B.; Christ-Crain M.. Neuroendocrinology Letters. 2008.

Copeptin: A new and promising diagnostic and prognostic marker

Katan M.; Muller B.; Christ-Crain M.. Critical care (London, England). 2008.

Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay

Katan M.; Morgenthaler N.G.; Dixit K.C.S.; Rutishauser J.; Brabant G.E.; Muller B.; Christ-Crain M.. Journal of Clinical Endocrinology and Metabolism. 2007.

Migraine in women

Katan M.; Kappos L.. Gynakologie. 2006.